|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$84,749.35 |
2.50% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$81,401.18 |
2.41% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$79,027.73 |
2.34% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$79,129.98 |
2.34% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$78,197.13 |
2.31% |
| Steris Plc |
STE |
G8473T100 |
298 |
$77,351.86 |
2.29% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$75,746.24 |
2.24% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$75,195.84 |
2.22% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$73,974.05 |
2.19% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$74,183.76 |
2.19% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$73,454.08 |
2.17% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$73,453.91 |
2.17% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$73,492.65 |
2.17% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$72,820.56 |
2.15% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$72,275.44 |
2.14% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$72,163.39 |
2.13% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$71,517.87 |
2.11% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$71,442.00 |
2.11% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$71,227.66 |
2.10% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$70,945.65 |
2.10% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$70,703.50 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$70,256.43 |
2.08% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$69,264.32 |
2.05% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$68,722.32 |
2.03% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$68,433.07 |
2.02% |
| Waters Corporation |
WAT |
941848103 |
147 |
$68,516.70 |
2.02% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$67,445.58 |
1.99% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,195.78 |
1.99% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$67,076.16 |
1.98% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$66,498.75 |
1.97% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$66,516.78 |
1.97% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$66,717.62 |
1.97% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$66,210.54 |
1.96% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$65,329.08 |
1.93% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$64,779.75 |
1.91% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$63,877.37 |
1.89% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,120.00 |
1.89% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$63,563.45 |
1.88% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$63,345.03 |
1.87% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$63,258.45 |
1.87% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$62,986.69 |
1.86% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$62,715.20 |
1.85% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$62,392.57 |
1.84% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$60,444.21 |
1.79% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$59,934.94 |
1.77% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$58,073.59 |
1.72% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$57,534.82 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$56,885.88 |
1.68% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,543.73 |
1.32% |
| US Dollar |
$USD |
|
23,183 |
$23,183.34 |
0.69% |
| Japanese Yen |
$JPY |
|
237,600 |
$1,490.87 |
0.04% |
| Euro |
$EUR |
|
0 |
$0.05 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|